Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
MST1	4485	broad.mit.edu	37	3	49723639	49723639	+	3'UTR	SNP	C	C	G	rs141558578	by1000genomes	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr3:49723639C>G	ENST00000383728.3	-	0	954				MST1_ENST00000449682.2_Intron|AC099668.5_ENST00000563780.1_RNA|MST1_ENST00000494828.2_5'Flank			P26927	HGFL_HUMAN	macrophage stimulating 1 (hepatocyte growth factor-like)	NA		NA		NA	proteolysis	extracellular region	serine-type endopeptidase activity			NS(4)|breast(1)|central_nervous_system(1)|endometrium(10)|kidney(1)|large_intestine(1)|lung(9)|prostate(2)|skin(9)|stomach(1)|urinary_tract(2)	41				BRCA - Breast invasive adenocarcinoma(193;4.47e-05)|Kidney(197;0.00216)|KIRC - Kidney renal clear cell carcinoma(197;0.00244)		AGCAGGCGCTCCACTCAGCCC	0.701		NA				NA		NA		NA			C	192	0.09	0.09	0.1	2184	0.09	0.8865	,	,	NA	0.0421	0.08	NA	NA	0.1283	0.5649	LOWCOV	NA	NA	3e-04	SNP	GBM(110;181 1524 8005 22865 46297)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000173531	HGNC:7380	NM_020998	Approved	uc003cxg.3	NA	A6NLA3|A8MSX3|Q13350|Q14870|Q6GTN4	ENST00000383728.3	37																																																																																				MST1-201	KNOWN	basic	protein_coding	NA	protein_coding		2.799989	KEEP	NA	-	8.108431	0.09375	3	29	G	PoN.13Oct2012	Reference	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	1	0.8868762	2	34	0	33	3	32	0	33	2	0	0	0	0	0	0	3	32	0	33	2	TP
SDHAP1	0	broad.mit.edu	37	3	195701327	195701327	+	RNA	SNP	T	T	C	rs148798763	by1000genomes	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr3:195701327T>C	ENST00000427841.1	-	0	1497					NR_003264.2					NA		NA		NA							NA						CCAGGTCCAATAGCGAGTTTG	0.597		NA				NA		NA		NA				13	0.01	0.01	0.01	2184	0.0035	0.9977	,	,	NA	0.0022	0.004	NA	NA	0.0059	0.8675	LOWCOV	NA	NA	0.0039	SNP	Ovarian(67;1158 1227 12109 20189 43170)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA										NA		ENST00000427841.1	37																																																																																				SDHAP1-002	KNOWN	basic	processed_transcript	NA	pseudogene	OTTHUMT00000341367.1	-26.479401	KEEP	NA	-	7.305333	0.022556	3	130	---	---	---	---	1	0.2105439	3	29	0	155	3	147	0	155	2	0	0	0	0	0	0	3	147	0	155	2	TP
ANKS1A	23294	broad.mit.edu	37	6	34985340	34985340	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr6:34985340G>A	ENST00000360359.3	+	11	1652	c.1514G>A	c.(1513-1515)gGc>gAc	p.G505D	ANKS1A_ENST00000535627.1_Intron	NM_015245.2	NP_056060.2	Q92625	ANS1A_HUMAN	ankyrin repeat and sterile alpha motif domain containing 1A	505		NA		NA		cytoplasm	protein binding			cervix(2)|endometrium(3)|large_intestine(4)|lung(16)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	31						CTCCTCCACGGCTCCTCCCCG	0.701		NA				NA		NA		NA				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	33	38	36	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	34985340	NA	2203	4300	6503	SO:0001583	missense			ENSG00000064999	HGNC:20961	XM_166478	Approved	uc003ojx.4	NA	A2RUC1|Q5JYI9|Q5SYR2|Q86WQ7	ENST00000360359.3	37	CCDS4798.1	.	.	.	.	.	.	.	.	.	.	G	22.1	4.243051	0.79912	.	.	ENSG00000064999	ENST00000360359	T	0.58797	0.31	5.05	5.05	0.67936	.	0.000000	0.50627	D	0.000117	T	0.69061	0.3069	M	0.62723	1.935	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	T	0.72181	-0.4368	10	0.72032	D	0.01	-25.8785	16.9636	0.86279	0.0:0.0:1.0:0.0	.	505	Q92625	ANS1A_HUMAN	D	505	ENSP00000353518:G505D	ENSP00000353518:G505D	G	+	2	0	ANKS1A	35093318	1.000000	0.71417	1.000000	0.80357	1.000000	0.99986	9.005000	0.93587	2.510000	0.84645	0.655000	0.94253	GGC	ANKS1A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040262.1	45.125332	KEEP	NA	+	46.714074	0.321429	18	38	---	---	---	---	1	0.9992163	15	18	0	55	19	44	0	55	2	0	0	0	0	0	0	19	44	0	55	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome	NA				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	112	104	107	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	140453136	NA	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	93.345646	KEEP	NA	-	93.921325	0.405405	30	44	---	---	---	---	1	0.999942	15	12	0	138	34	47	0	138	2	1	1	304	346	0	517	34	47	0	138	2	TP
SLC39A14	23516	broad.mit.edu	37	8	22275185	22275185	+	Missense_Mutation	SNP	A	A	T			THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr8:22275185A>T	ENST00000359741.5	+	8	1344	c.1169A>T	c.(1168-1170)aAc>aTc	p.N390I	SLC39A14_ENST00000381237.1_Missense_Mutation_p.N390I|SLC39A14_ENST00000240095.6_Missense_Mutation_p.N390I|SLC39A14_ENST00000289952.5_Missense_Mutation_p.N390I	NM_015359.4	NP_056174.2	Q15043	S39AE_HUMAN	solute carrier family 39 (zinc transporter), member 14	390		NA		NA		endoplasmic reticulum|Golgi apparatus|integral to membrane|lamellipodium|plasma membrane	zinc ion transmembrane transporter activity			NS(1)|endometrium(4)|large_intestine(2)|lung(4)|prostate(1)	12				Colorectal(74;0.019)|COAD - Colon adenocarcinoma(73;0.0731)		ATCCTGCTCAACGCTGGGATG	0.547		NA				NA		NA		NA				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	177	138	151	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	22275185	NA	2203	4300	6503	SO:0001583	missense			ENSG00000104635	HGNC:20858	XM_046677	Approved	uc011kzh.2	NA	A6NH98|D3DSR4|Q6ZME8|Q96BB3	ENST00000359741.5	37	CCDS6030.1	.	.	.	.	.	.	.	.	.	.	A	22.5	4.303742	0.81136	.	.	ENSG00000104635	ENST00000359741;ENST00000240095;ENST00000381237;ENST00000289952	T;T;T;T	0.48836	0.8;0.8;0.8;0.8	6.17	5.01	0.66863	.	0.000000	0.85682	D	0.000000	T	0.69360	0.3102	M	0.82823	2.61	0.58432	D	0.999999	D;D;D	0.89917	0.998;1.0;1.0	D;D;D	0.83275	0.983;0.996;0.996	T	0.72686	-0.4218	10	0.62326	D	0.03	-28.6944	11.5887	0.50933	0.9297:0.0:0.0703:0.0	.	390;390;390	Q15043-2;Q15043;B6EU88	.;S39AE_HUMAN;.	I	390	ENSP00000352779:N390I;ENSP00000240095:N390I;ENSP00000370635:N390I;ENSP00000289952:N390I	ENSP00000240095:N390I	N	+	2	0	SLC39A14	22331130	1.000000	0.71417	0.969000	0.41365	0.723000	0.41478	7.352000	0.79404	1.146000	0.42352	0.533000	0.62120	AAC	SLC39A14-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000215038.2	177.847323	KEEP	NA	+	178.643829	0.42069	61	84	---	---	---	---	1	1	22	32	0	188	72	102	0	188	2	0	0	0	0	0	0	72	102	0	188	2	TP
PSMA4	5685	broad.mit.edu	37	15	78841287	78841287	+	3'UTR	SNP	A	A	T			THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr15:78841287A>T	ENST00000044462.7	+	0	937				PSMA4_ENST00000559082.1_3'UTR|PSMA4_ENST00000558341.1_3'UTR|PSMA4_ENST00000558281.1_3'UTR|PSMA4_ENST00000558094.1_3'UTR|PSMA4_ENST00000413382.2_3'UTR|PSMA4_ENST00000560217.1_3'UTR	NM_002789.4	NP_002780.1	P25789	PSA4_HUMAN	proteasome (prosome, macropain) subunit, alpha type, 4	NA		NA		NA	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|G1/S transition of mitotic cell cycle|interspecies interaction between organisms|M/G1 transition of mitotic cell cycle|mRNA metabolic process|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|regulation of apoptosis|regulation of cellular amino acid metabolic process|S phase of mitotic cell cycle|viral reproduction	cytoplasm|nucleus|proteasome core complex, alpha-subunit complex	identical protein binding|threonine-type endopeptidase activity			kidney(2)|large_intestine(2)|lung(2)|ovary(1)|skin(1)|upper_aerodigestive_tract(1)	9						GGATAAATAGAATCAGAGATT	0.378		NA				NA		NA		NA				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	33	34	34	NA	NA	NA	NA	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	78841287	NA	2195	4292	6487	SO:0001624	3_prime_UTR_variant			ENSG00000041357	HGNC:9533	NM_002789	Approved	uc010blf.3	NA	D3DW86|Q53XP2|Q8TBD1	ENST00000044462.7	37	CCDS10303.1																																																																																			PSMA4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000290107.5	32.595457	KEEP	NA	+	32.62908	0.461538	12	14	---	---	---	---	1	1	220	346	0	45	12	15	0	45	2	0	0	0	0	0	0	12	15	0	45	2	TP
DVL2	1856	broad.mit.edu	37	17	7129384	7129384	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3GX-Tumor-SM-2HRM7	THCA-TCGA-EL-A3GX-Normal-SM-2HRMC	g.chr17:7129384G>T	ENST00000005340.5	-	15	2293	c.2011C>A	c.(2011-2013)Cct>Act	p.P671T	DVL2_ENST00000575458.1_Missense_Mutation_p.P665T|MIR324_ENST00000362183.1_RNA	NM_004422.2	NP_004413.1	O14641	DVL2_HUMAN	dishevelled segment polarity protein 2	671		NA		NA	canonical Wnt receptor signaling pathway involved in regulation of cell proliferation|intracellular signal transduction|neural tube closure|positive regulation of JUN kinase activity|positive regulation of protein phosphorylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription, DNA-dependent|segment specification|transcription from RNA polymerase II promoter	cytosol|nucleus|plasma membrane	frizzled binding|identical protein binding|signal transducer activity			breast(2)|endometrium(3)|kidney(1)|large_intestine(11)|lung(7)|skin(1)	25						GCCATGCCAGGGGGCGGTCCA	0.667		NA				NA		NA		NA				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	34	39	37	NA	NA	NA	NA	17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	7129384	NA	2203	4299	6502	SO:0001583	missense			ENSG00000004975	HGNC:3086	NM_004422	Approved	uc002gez.1	NA	D3DTN3|Q53XM0	ENST00000005340.5	37	CCDS11091.1	.	.	.	.	.	.	.	.	.	.	G	14.43	2.533711	0.45073	.	.	ENSG00000004975	ENST00000005340	T	0.04603	3.59	5.74	4.75	0.60458	Dishevelled C-terminal (1);	0.058111	0.64402	D	0.000001	T	0.12774	0.0310	M	0.83118	2.625	0.45541	D	0.998498	P;P	0.46064	0.872;0.872	P;P	0.47941	0.562;0.562	T	0.12967	-1.0527	10	0.21540	T	0.41	-5.2434	12.9814	0.58567	0.0798:0.0:0.9202:0.0	.	665;671	B4DLQ0;O14641	.;DVL2_HUMAN	T	671	ENSP00000005340:P671T	ENSP00000005340:P671T	P	-	1	0	DVL2	7070108	0.997000	0.39634	0.954000	0.39281	0.992000	0.81027	2.602000	0.46257	1.399000	0.46721	0.561000	0.74099	CCT	DVL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000219999.2	-12.377982	KEEP	NA	-	6.496161	0.046512	4	82	---	---	---	---	1	0.9793907	11	121	0	85	5	88	0	85	2	0	0	0	0	0	0	5	88	0	85	2	TP
